Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share - Computation of Diluted Net Loss Per Share of Common Stock, Because Their Effect was Anti-Dilutive- (Details)

v3.22.2.2
Earnings (Loss) Per Share - Computation of Diluted Net Loss Per Share of Common Stock, Because Their Effect was Anti-Dilutive- (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Stock-based awards and warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) 3,364,289 3,987,285 10,129,870 3,987,285
Convertible notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) 0 0 7,833,666 0